Anergis SA

Anergis is a clinical-stage biopharmaceutical company based in Switzerland.

Anergis discovers and develops proprietary synthetic allergy vaccines with the aim to provide allergy patients and doctors with a significantly improved treatment option: ultra-fast immunotherapy.

Anergis COP allergy vaccines are pharmaceutical-grade products based on Contiguous Overlapping Peptides (COPs) and only need to be administered for 2 months in order to achieve long-lasting desensitization.

Anergis strives to improve the medical treatment of patients suffering from allergies by promoting a shift in treatment paradigms from short-term symptomatic relief to long-term cure from allergies by ultra-fast desensitization.